Cephalon, Cima Sue Mylan To Block Generic Fentora

Law360, New York (February 28, 2011, 2:34 PM EST) -- Cephalon Inc. and Cima Labs Inc. launched a patent infringement suit against Mylan Inc. in Delaware on Friday, targeting the company over its attempts to market a generic version of Cephalon's cancer painkiller drug Fentora.

Douglas E. McCann of Fish & Richardson PC lodged the suit in the U.S. District Court for the District of Delaware, accusing the generic-drug maker of infringing U.S. Patent Numbers 6,200,604 and 6,974,590.

According to the suit, both patents — which Cima owns and licenses exclusively to Cephalon — cover methods...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.